Form 4: Elanco Executive Acquires Deferred Stock Units

Rajeev A. Modi, an executive at Elanco Animal Health, acquired deferred stock units representing the right to receive common stock or cash.

Summary

• Rajeev A. Modi, an Executive Vice President at Elanco Animal Health, acquired 121.1391 deferred stock units on January 10, 2025.
• These deferred stock units represent the right to receive one share of Elanco common stock or the cash equivalent.
• The units will settle in cash or shares of common stock following termination of employment or during a specified future year.
• The price of the underlying common stock at the time of the transaction was $11.43.

Sentiment

Score: 7

Explanation: The document reflects a routine executive compensation transaction, which is generally neutral to positive for the company's outlook.

Future Outlook

The deferred stock units will settle in cash or shares of common stock following termination of employment or during a specified future year.

Industry Context

This is a standard transaction for executive compensation in publicly traded companies, aligning executive interests with shareholder value.

Comparison to Industry Standards

• Deferred stock unit grants are a common form of executive compensation in the pharmaceutical and animal health industries.
• Companies like Zoetis and IDEXX Laboratories also use similar equity-based compensation plans for their executives.
• The vesting and settlement terms are typical for such grants, often tied to employment duration or specific performance metrics.

Stakeholder Impact

• The transaction aligns executive interests with shareholder value through equity-based compensation.
• The impact on employees is indirect, as it relates to executive compensation.

Key Dates

Keywords

Elanco Animal Health, Deferred Stock Units, Executive Compensation, Rajeev A. Modi, Stock Acquisition, Form 4